This topic contains a solution. Click here to go to the answer

Author Question: The term that describes an immunosuppressed patient's inability to react to a skin test is ... (Read 22 times)

abc

  • Hero Member
  • *****
  • Posts: 543
The term that describes an immunosuppressed patient's inability to react to a skin test is __________________.
 
  ANS:

Question 2

An organism that can cross from an animal species to humans is a(n) ____________organis m.
 
  ANS:



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Edwyer

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

anergic

Anergic is the term that describes an immunosuppressed patient's ability to react to a skin test.

Answer to Question 2

zoonotic

A zoonotic organism is an organism that can cross from an animal species to humans.




abc

  • Member
  • Posts: 543
Reply 2 on: Jul 11, 2018
Gracias!


debra928

  • Member
  • Posts: 342
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Tobacco depletes the body of vitamins A, C, and E, which can result in any of the following: dry hair, dry skin, dry eyes, poor growth, night blindness, abscesses, insomnia, fatigue, reproductive system problems, sinusitis, pneumonia, frequent respiratory problems, skin disorders, weight loss, rickets, osteomalacia, nervousness, muscle spasms, leg cramps, extremity numbness, bone malformations, decayed teeth, difficulty in walking, irritability, restlessness, profuse sweating, increased uric acid (gout), joint damage, damaged red blood cells, destruction of nerves, infertility, miscarriage, and many types of cancer.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library